Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hari Manev

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Biomolecular Concepts|December 2, 2014
Progress in mitochondrial epigeneticsHari Manev, Svetlana Dzitoyeva
European Journal of Pharmacology|June 18, 2002
DNA hypomethylating agents 5-aza-2'-deoxycytidine and valproate increase neuronal 5-lipoxygenase mRNAHari Manev, Tolga Uz
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|November 20, 2009
Interactions with GluR1 AMPA receptors could influence the therapeutic usefulness of minocycline in ALSHari Manev, Radmila Manev
Journal of Biomedical Discovery and Collaboration|May 26, 2006
Nomen est Omen: do antidepressants increase p11 or S100A10?Hari Manev, Radmila Manev
Neuropharmacology|September 28, 2010
Effects of minocycline on cocaine sensitization and phosphorylation of GluR1 receptors in 5-lipoxygenase deficient miceHu Chen, Hari Manev
Cardiovascular Psychiatry and Neurology|July 31, 2010
Benefits of neuropsychiatric phenomics: example of the 5-lipoxygenase-leptin-Alzheimer connectionHari Manev, Radmila Manev
Critical Reviews in Neurobiology|December 8, 2004
5-Lipoxygenase as a putative link between cardiovascular and psychiatric disordersRadmila Manev, Hari Manev
Medical Hypotheses|November 10, 2005
5-Lipoxygenase (ALOX5) and FLAP (ALOX5AP) gene polymorphisms as factors in vascular pathology and Alzheimer's diseaseHari Manev, Radmila Manev
Trends in Pharmacological Sciences|March 4, 2006
Clock genes: influencing and being influenced by psychoactive drugsHari Manev, Tolga Uz
Medical Hypotheses|June 27, 2006
Could treatment with arundic acid (ONO-2506) increase vulnerability for depression?Radmila Manev, Hari Manev
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Biomolecular Concepts|December 2, 2014
Progress in mitochondrial epigeneticsHari Manev, Svetlana Dzitoyeva
European Journal of Pharmacology|June 18, 2002
DNA hypomethylating agents 5-aza-2'-deoxycytidine and valproate increase neuronal 5-lipoxygenase mRNAHari Manev, Tolga Uz
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|November 20, 2009
Interactions with GluR1 AMPA receptors could influence the therapeutic usefulness of minocycline in ALSHari Manev, Radmila Manev
Journal of Biomedical Discovery and Collaboration|May 26, 2006
Nomen est Omen: do antidepressants increase p11 or S100A10?Hari Manev, Radmila Manev
Neuropharmacology|September 28, 2010
Effects of minocycline on cocaine sensitization and phosphorylation of GluR1 receptors in 5-lipoxygenase deficient miceHu Chen, Hari Manev
Cardiovascular Psychiatry and Neurology|July 31, 2010
Benefits of neuropsychiatric phenomics: example of the 5-lipoxygenase-leptin-Alzheimer connectionHari Manev, Radmila Manev
Critical Reviews in Neurobiology|December 8, 2004
5-Lipoxygenase as a putative link between cardiovascular and psychiatric disordersRadmila Manev, Hari Manev
Medical Hypotheses|November 10, 2005
5-Lipoxygenase (ALOX5) and FLAP (ALOX5AP) gene polymorphisms as factors in vascular pathology and Alzheimer's diseaseHari Manev, Radmila Manev
Trends in Pharmacological Sciences|March 4, 2006
Clock genes: influencing and being influenced by psychoactive drugsHari Manev, Tolga Uz
Medical Hypotheses|June 27, 2006
Could treatment with arundic acid (ONO-2506) increase vulnerability for depression?Radmila Manev, Hari Manev
Pageof 7